Co-enzyme Q10: a new drug for cardiovascular disease

HOME

HELP

FEEDBACK

SUBSCRIPTIONS

Articles

Co-enzyme Q10: a new drug for cardiovascular disease

S Greenberg and WH Frishman

Co-enzyme Q10 (ubiquinone) is a naturally occurring substance which has properties potentially beneficial for preventing cellular damage during myocardial ischemia and reperfusion. It plays a role in oxidative phosphorylation and has membrane stabilizing activity. The substance has been used in oral form to treat various cardiovascular disorders including angina pectoris, hypertension, and congestive heart failure. Its clinical importance is now being established in clinical trails worldwide.
Add to CiteULike CiteULike Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

M. Kitano, F. Mizuhashi, H. Kubo, H. Kishida, K. Fujii, M. Kitahara, and K. Hosoe
Evaluation of the Mutagenic and Genotoxic Potential of Ubiquinol
International Journal of Toxicology, November 1, 2007; 26(6): 533 - 544.
[Abstract] [Full Text] [PDF]

S. A Shah, S. Sander, D. Cios, J. Lipeika, J. Kluger, and C M. White
Electrocardiographic and Hemodynamic Effects of Coenzyme Q10 in Healthy Individuals: A Double-Blind, Randomized Controlled Trial
Ann. Pharmacother., March 1, 2007; 41(3): 420 - 425.
[Abstract] [Full Text] [PDF]

G.T. Chew and G.F. Watts
Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis'
QJM, August 1, 2004; 97(8): 537 - 548.
[Abstract] [Full Text] [PDF]

C. Crone, G. Gabriel, and T. N. Wise
Non-Herbal Nutritional Supplements--The Next Wave: A Comprehensive Review of Risks and Benefits for the C-L Psychiatrist
Psychosomatics, August 1, 2001; 42(4): 285 - 299.
[Abstract] [Full Text] [PDF]

M. Khatta, B. S. Alexander, C. M. Krichten, M. L. Fisher, R. Freudenberger, S. W. Robinson, and S. S. Gottlieb
The Effect of Coenzyme Q10 in Patients with Congestive Heart Failure
Ann Intern Med, April 18, 2000; 132(8): 636 - 640.
[Abstract] [Full Text] [PDF]

H. G. Preuss, S. T. Jarrell, R. Scheckenbach, S. Lieberman, and R. A. Anderson
Comparative Effects of Chromium, Vanadium and Gymnema Sylvestre on Sugar-Induced Blood Pressure Elevations in SHR
J. Am. Coll. Nutr., April 1, 1998; 17(2): 116 - 123.
[Abstract] [Full Text] [PDF]

D. P. Taggart, M. Jenkins, J. Hooper, L. Hadjinikolas, M. Kemp, D. Hue, and G. Bennett
Effects of Short-Term Supplementation With Coenzyme Q10 on Myocardial Protection During Cardiac Operations
Ann. Thorac. Surg., March 1, 1996; 61(3): 829 - 833.
[Abstract] [Full Text]

J. A. Crestanello, J. Kamelgard, D. M. Lingle, S. A. Mortensen, M. Rhode, and G. J. R. Whitman
ELUCIDATION OF A TRIPARTITE MECHANISM UNDERLYING THE IMPROVEMENT IN CARDIAC TOLERANCE TO ISCHEMIA BY COENZYME Q10 PRETREATMENT
J. Thorac. Cardiovasc. Surg., February 1, 1996; 111(2): 443 - 450.
[Abstract] [Full Text]

				S. A Shah, S. Sander, D. Cios, J. Lipeika, J. Kluger, and C M. White Electrocardiographic and Hemodynamic Effects of Coenzyme Q10 in Healthy Individuals: A Double-Blind, Randomized Controlled Trial Ann. Pharmacother., March 1, 2007; 41(3): 420 - 425. [Abstract] [Full Text] [PDF]

				G.T. Chew and G.F. Watts Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis' QJM, August 1, 2004; 97(8): 537 - 548. [Abstract] [Full Text] [PDF]

				C. Crone, G. Gabriel, and T. N. Wise Non-Herbal Nutritional Supplements--The Next Wave: A Comprehensive Review of Risks and Benefits for the C-L Psychiatrist Psychosomatics, August 1, 2001; 42(4): 285 - 299. [Abstract] [Full Text] [PDF]

				M. Khatta, B. S. Alexander, C. M. Krichten, M. L. Fisher, R. Freudenberger, S. W. Robinson, and S. S. Gottlieb The Effect of Coenzyme Q10 in Patients with Congestive Heart Failure Ann Intern Med, April 18, 2000; 132(8): 636 - 640. [Abstract] [Full Text] [PDF]

				H. G. Preuss, S. T. Jarrell, R. Scheckenbach, S. Lieberman, and R. A. Anderson Comparative Effects of Chromium, Vanadium and Gymnema Sylvestre on Sugar-Induced Blood Pressure Elevations in SHR J. Am. Coll. Nutr., April 1, 1998; 17(2): 116 - 123. [Abstract] [Full Text] [PDF]

				D. P. Taggart, M. Jenkins, J. Hooper, L. Hadjinikolas, M. Kemp, D. Hue, and G. Bennett Effects of Short-Term Supplementation With Coenzyme Q10 on Myocardial Protection During Cardiac Operations Ann. Thorac. Surg., March 1, 1996; 61(3): 829 - 833. [Abstract] [Full Text]

				J. A. Crestanello, J. Kamelgard, D. M. Lingle, S. A. Mortensen, M. Rhode, and G. J. R. Whitman ELUCIDATION OF A TRIPARTITE MECHANISM UNDERLYING THE IMPROVEMENT IN CARDIAC TOLERANCE TO ISCHEMIA BY COENZYME Q10 PRETREATMENT J. Thorac. Cardiovasc. Surg., February 1, 1996; 111(2): 443 - 450. [Abstract] [Full Text]